Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-α4 antibody in adjuvant arthritis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Springer Seminars in Immunopathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00196098PMID 7570293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular cell adhesion molecule 1 and a4 and a 1 integrins in lymphocyte aggregates in S jogren's syndrome and rheumatoid arthritis

  2004cited by this paper
• Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment.

  1994cited by this paper
• The pathophysiologic role of alpha 4 integrins in vivo.

  1994cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994influential reference
• A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo

  1993cited by this paper
• The alpha 4 beta 1/VCAM-1 adhesion pathway in physiology and disease.

  1993cited by this paper
• In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells.

  1993cited by this paper
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

  1993cited by this paper
• Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.

  1993cited by this paper
• Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease.

  1993cited by this paper
• α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1

  1993cited by this paper
• Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

  1993cited by this paper
• Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.

  1993cited by this paper
• Beta 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns.

  1993cited by this paper
• The α4β1/VCAM-1 adhesion pathway in physiology and disease

  1993cited by this paper
• Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1.

  1993cited by this paper
• Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

  1993cited by this paper
• Monoclonal antibodies to the integrin α−4 subunit inhibit the murine contact hypersensitivity response

  1993cited by this paper
• Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

  1993cited by this paper
• Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes.

  1993cited by this paper
• Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes.

  1992cited by this paper
• Cell adhesion/signalling: biology and clinical applications

  1992cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

  1992cited by this paper
• Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

  1992cited by this paper
• Cellular and Humoral Immune Response Against Articular Chondrocytes and Proteoglycans in Rheumatoid Arthritis

  1992cited by this paper
• Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules.

  1992cited by this paper
• Leukocyte integrins: structure, function and regulation of their activity.

  1992cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

  1992cited by this paper
• Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor.

  1992cited by this paper
• Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

  1991cited by this paper
• Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.

  1991cited by this paper
• Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody.

  1991cited by this paper
• Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin.

  1991cited by this paper
• Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

  1991cited by this paper
• Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active alpha 4 beta 1-fibronectin receptors upon B cell activation.

  1991cited by this paper
• Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

  1991cited by this paper
• Expression of the CD2 Activation Epitope T11‐3 (CD2R) on T Cells in Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Lyme Disease: Phenotypic and Functional Analysis

  1991cited by this paper
• Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.

  1991cited by this paper
• Differential expression of VLA‐4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active α4β1‐fibronectin receptors upon B cell activation

  1991cited by this paper
• Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1.

  1990cited by this paper
• Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies.

  1990cited by this paper
• VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

  1990cited by this paper
• Leukocyte adhesion to endothelium in inflammation.

  1990cited by this paper
• An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1- independent, triggered through the human VLA-4 integrin

  1990cited by this paper
• Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1

  1990cited by this paper
• Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.

  1990cited by this paper
• VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

  1990cited by this paper
• Inside the thymus, Mls antigen is exclusively presented by B lymphocytes.

  1990cited by this paper
• Adhesion molecules controlling lymphocyte migration.

  1989cited by this paper
• Very late activation antigen on synovial fluid T cells from patients with rheumatoid arthritis and other rheumatic diseases.

  1989cited by this paper
• Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin

  1989cited by this paper
• Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.

  1989cited by this paper
• Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.

  1989cited by this paper
• Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation.

  1988cited by this paper
• Lymphocytapheresis--a feasible treatment for rheumatoid arthritis.

  1986cited by this paper
• Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation.

  1986cited by this paper
• VLA‐3: A novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization

  1986cited by this paper
• A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.

  1985cited by this paper
• T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis.

  1985cited by this paper
• Lines of T lymphocytes induce or vaccinate against autoimmune arthritis.

  1983cited by this paper
• Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.

  1982cited by this paper
• Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis.

  1981cited by this paper
• Lymphocyte Involvement in Rheumatoid Arthritis

  1977cited by this paper
• Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

  1977cited by this paper

• The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis

  2017cites this paper
• Importance of integrin receptors in the field of pharmaceutical & medical science

  2013cites this paper
• Hypoxia and hypoxia mimetics inhibit TNF-dependent VCAM1 induction in the 5A32 endothelial cell line via a hypoxia inducible factor dependent mechanism.

  2012cites this paper
• Combinatorial approaches to inhibitors of VLA-4: Piperazine-peptoid-bisarylureas

  2004cites this paper
• The discovery of VLA-4 antagonists.

  2004cites this paper
• Vascular endothelium and immune responses: implications for inflammation and angiogenesis.

  2004cites this paper
• Alpha 4 integrin antagonists.

  2002cites this paper
• Design and synthesis of potent and selective inhibitors of integrin VLA-4.

  2001cites this paper
• E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat.

  2001cites this paper
• Integrin expression at the bone/biomaterial interface.

  2001cites this paper
• Use of biologics in the treatment of childhood rheumatic diseases

  2000cites this paper
• T-cell trafficking into sites of inflammation.

  2000cites this paper
• Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.

  2000cites this paper
• Cell-cell interactions in synovitis: Endothelial cells and immune cell migration

  2000cites this paper
• Synthesis of a peptidomimetic tricyclic tetrahydrobenzo[ij]quinoline as a VLA-4 antagonist.

  2000cites this paper
• The role of alpha(4) and LFA-1 integrins in selectin-independent monocyte and neutrophil migration to joints of rats with adjuvant arthritis.

  2000cites this paper
• Cytokine mRNA in the Joints and Draining Lymph Nodes of Rats with Adjuvant Arthritis and Effects of Cyclosporin A

  2000cites this paper
• Adhesion Molecules in Inflammatory Diseases

  1998cites this paper
• Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis.

  1998cites this paper
• Anti-adhesion therapy.

  1997cites this paper
• Biologic agents for treating rheumatoid arthritis. Concepts and progress.

  1997cites this paper
• Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.

  1997cites this paper
• Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen‐4 integrins suppresses neutrophil and T‐lymphocyte migration to the joints and improves clinical disease

  1996cites this paper
• Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats.

  1996cites this paper